Talik Tahmasian, | |
10465 Sunland Blvd, Sunland, CA 91040-1905 | |
(818) 352-4129 | |
Not Available |
Full Name | Talik Tahmasian |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 10465 Sunland Blvd, Sunland, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588179428 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 77895 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Talik Tahmasian, 7223 Apperson St Unit 111, Tujunga, CA 91042-1877 Ph: (818) 618-6488 | Talik Tahmasian, 10465 Sunland Blvd, Sunland, CA 91040-1905 Ph: (818) 352-4129 |
News Archive
Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.
Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.
The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, today announced that the staff of the Nasdaq Stock Market has granted the Company an extension of the deadline to regain compliance with Nasdaq Listing Rule 5550(b).
› Verified 9 days ago
Armineh Gasparian, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10050 La Canada Way, Sunland, CA 91040 Phone: 818-307-0454 | |
Sana Fazai, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10465 Sunland Blvd, Sunland, CA 91040 Phone: 818-352-4129 | |
Klarinda Barkhordarian Boghosian, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11000 Scoville Ave, Sunland, CA 91040 Phone: 818-489-7846 | |
Dr. Crisanto Ortiz Ortiz-luis, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8341 Jayseel St, Sunland, CA 91040 Phone: 818-293-1949 | |
Rajya Lakshmi Meka, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10465 Sunland Blvd, Sunland, CA 91040 Phone: 818-352-4129 | |
Karina Keshishian, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8441 Foothill Blvd, Sunland, CA 91040 Phone: 818-925-1321 Fax: 818-446-2241 |